Stocks Consumer discretionary CL
NYSE · Consumer discretionaryColgate Palmolive Co (CL)
Colgate Palmolive Co brought in $21.3B of revenue over the twelve months to September 30, 2026, up 5.9% from a year earlier. Net income was $2.1B, a net margin of 9.7%. Operating cash flow minus capital spending left $3.6B of free cash flow in fiscal 2025. At September 30, 2026 it held $1.5B in cash against $7.2B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 30, 2026.
Key facts about Colgate Palmolive Co
- Net worth
- Colgate Palmolive Co has a market value (market cap) of $78.2B at the latest share price, and shareholders' equity of $288M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $20.4B (+1.4% year on year), with net income of $2.1B. Over the 12 months to September 30, 2026: revenue $21.3B, net income $2.1B.
- Cash flow
- In fiscal 2025 operations brought in $4.2B of cash; after $564M of capital spending, free cash flow was $3.6B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 30, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Colgate Palmolive Co's next report is expected around January 29, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Colgate Palmolive Co declared dividends of $2.08 per share in fiscal 2025, a yield of 2.12% at the current price.
What Colgate Palmolive Co does
Colgate-Palmolive manufactures and sells oral hygiene, personal care, home cleaning, and pet nutrition products. Its product lines include toothpaste, toothbrushes, mouthwashes, bar soaps, shower gels, deodorants, dishwashing detergents, household cleaners, and specialized pet foods distributed to retail stores, pharmacies, and veterinary clinics. Its shares trade on NYSE under the ticker CL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $20.4B | $2.1B | $2.63 | $3.6B |
| 2024 | $20.1B | $2.9B | $3.51 | $3.5B |
| 2023 | $19.5B | $2.3B | $2.77 | $3B |
| 2022 | $18B | $1.8B | $2.13 | $1.9B |
| 2021 | $17.4B | $2.2B | $2.55 | $2.8B |
| 2020 | $16.5B | $2.7B | $3.14 | $3.3B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CL ranks in Consumer discretionary
Dividends
Colgate Palmolive Co declared $2.08 per share in fiscal 2025. At the current price that is a yield of 2.12%. It paid out $1.8B in cash dividends, 86% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $2.08 | $1.8B | 86% |
| 2024 | $2.48 | $1.8B | 62% |
| 2023 | $1.91 | $1.7B | 76% |
| 2022 | $1.86 | $1.7B | 95% |
| 2021 | $1.79 | $1.7B | 78% |
| 2020 | $1.75 | $1.7B | 61% |
Latest SEC filings
What Colgate Palmolive Co has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 30, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 4.6% to $5.4B versus the same quarter last year; diluted EPS $0.94 versus $0.91.
- October 30, 2026
- July 31, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 4.9% to $5.4B versus the same quarter last year; diluted EPS $0.86 versus $0.91.
- July 31, 2026
- June 24, 2026
- June 24, 2026
- June 1, 2026
- May 13, 2026
- May 1, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 8.4% to $5.3B versus the same quarter last year; diluted EPS $0.80 versus $0.85.
- May 1, 2026
What is CL worth? A DCF from its reported cash flow
Insider trades
What the people running Colgate Palmolive Co did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $7.6M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 5, 2026 | Norrington Lorrie MDirector | Exercised options | 4,170 | $298.4K |
| November 5, 2026 | Norrington Lorrie MDirector | Sold | 4,170 | $414.1K |
| November 5, 2026 | Wallace Noel R.Chairman, President & CEO, Director | Sold | 20,000 | $2M |
| November 4, 2026 | Hazlin JohnChief Growth Officer | Exercised options | 23,376 | $1.8M |
| November 4, 2026 | Hazlin JohnChief Growth Officer | Sold | 23,376 | $2.3M |
| November 4, 2026 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Exercised options | 19,938 | $1.5M |
| November 4, 2026 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Sold | 19,938 | $2M |
| October 1, 2026 | Bilbrey John PDirector | Received as pay | 271 | $23.7K |
Who owns CL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 7.52% | April 29, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 2,013 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 69,915,472 | -2,727,530 |
| Vanguard Capital Management LLC | 52,246,333 | +26,509 |
| State Street Corp | 47,020,966 | -698,516 |
| Vanguard Portfolio Management LLC | 24,021,137 | +198,391 |
| Geode Capital Management, LLC | 23,144,319 | +244,029 |
| Morgan Stanley | 22,072,925 | +1,191,571 |
| First Eagle Investment Management, LLC | 16,411,398 | +8,294,616 |
| Bank of New York Mellon Corp | 13,532,417 | +1,010,872 |
| Deutsche Bank AG\ | 11,751,973 | -176,188 |
| Norges Bank | 9,686,029 | new |
| Fmr LLC | 8,983,071 | -25,914 |
| Goldman Sachs Group Inc | 8,571,015 | -904,819 |
| Northern Trust Corp | 8,471,575 | -209,188 |
| Invesco Ltd. | 8,325,612 | -13,381 |
| State Farm Mutual Automobile Insurance Co | 6,730,570 | 0 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6,471,404 | -357,560 |
| Amundi | 6,218,257 | +1,033,918 |
| Bank of America Corp | 6,189,824 | -447,773 |
| Royal Bank of Canada | 5,591,400 | +651,387 |
| Legal & General Group Plc | 5,416,333 | -300,641 |
Insiders
18 insiders reported holding 947,179 shares in total, about $92.9M at the last price.
| Holder | Shares |
|---|---|
| Wallace Noel R.Chairman, President & CEO, Director | 359,700 |
| Daniels JenniferCLO and Secretary | 89,844 |
| Grant ShaneCOO, Americas | 79,503 |
| Sutula Stanley J IIIChief Financial Officer | 79,029 |
| Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | 74,01264,901 held indirectly |
| Norrington Lorrie MDirector | 43,383 |
| Bilbrey John PDirector | 40,725 |
| Cahill John TDirector | 28,373 |
| Hazlin JohnChief Growth Officer | 27,021 |
| Harris C MartinDirector | 24,517 |
Questions about CL
What does Colgate Palmolive Co do?
Colgate-Palmolive manufactures and sells oral hygiene, personal care, home cleaning, and pet nutrition products. Its product lines include toothpaste, toothbrushes, mouthwashes, bar soaps, shower gels, deodorants, dishwashing detergents, household cleaners, and specialized pet foods distributed to retail stores, pharmacies, and veterinary clinics. Its shares trade on NYSE under the ticker CL.
What is Colgate Palmolive Co's net worth?
Colgate Palmolive Co has a market value (market cap) of $78.2B at the latest share price, and shareholders' equity of $288M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Colgate Palmolive Co profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $2.1B on revenue of $21.3B, a net margin of 9.7%.
How much revenue does Colgate Palmolive Co make?
Over the twelve months to September 30, 2026 Colgate Palmolive Co reported revenue of $21.3B. That is 5.9% more than a year earlier.
When did Colgate Palmolive Co last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 30, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade from November 9, 2026.
When is Colgate Palmolive Co's next earnings report?
Colgate Palmolive Co's next report is expected around January 29, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Colgate Palmolive Co pay a dividend?
Yes. Colgate Palmolive Co declared dividends of $2.08 per share in fiscal 2025, a yield of 2.12% at the current price.
Similar companies
Compare CL with
Follow CL
Get an email when Colgate Palmolive Co files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Colgate Palmolive Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.